CD8A and neoplasm: However, in support of a role of SPMs in sustaining an anti-tumor cytotoxic response, it has been observed that RvD1 and its precursor (DHA) affect natural killer (NK) cells, the innate immune counterpart of CD8+ T cells, by preventing their death and sustaining their tumoricidal activity [38].